SEC Form 4 · accession 0001127602-15-013814
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 8:20 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 1, 2015 | M | 2,211 | $63.22 | A | 2,451 | D | |
| Common StockF2 | Apr 1, 2015 | S | 200 | $169.76 | D | 2,251 | D | |
| Common StockF3 | Apr 1, 2015 | S | 400 | $170.9125 | D | 1,851 | D | |
| Common StockF4 | Apr 1, 2015 | S | 600 | $172.6817 | D | 1,251 | D | |
| Common StockF5 | Apr 1, 2015 | S | 811 | $173.64 | D | 440 | D | |
| Common StockF6 | Apr 1, 2015 | S | 200 | $174.275 | D | 240 | D | |
| Common StockF7 | Apr 2, 2015 | M | 5,547 | $30.75 | A | 5,787 | D | |
| Common StockF8 | Apr 2, 2015 | S | 3,800 | $173.4398 | D | 1,987 | D | |
| Common StockF9 | Apr 2, 2015 | S | 1,547 | $174.3066 | D | 440 | D | |
| Common StockF10 | Apr 2, 2015 | S | 200 | $175.255 | D | 240 | D | |
| Common StockF7 | Apr 2, 2015 | M | 4,115 | $34.56 | A | 4,355 | D | |
| Common StockF11 | Apr 2, 2015 | S | 3,215 | $173.278 | D | 1,140 | D | |
| Common StockF12 | Apr 2, 2015 | S | 900 | $174.0178 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 548,421 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $63.22 | Apr 1, 2015 | M | 2,211 | D | Dec 31, 2010 | Dec 31, 2020 | Common Stock | 2,211 | 433,375 | D |
| Stock OptionsF7 | $30.75 | Apr 2, 2015 | M | 5,547 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 5,547 | 504,742 | D |
| Stock OptionsF7 | $34.56 | Apr 2, 2015 | M | 4,115 | D | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 4,115 | 135,810 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F10This transaction was executed in multiple trades at prices ranging from $175.09 to $175.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $172.90 to $173.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12This transaction was executed in multiple trades at prices ranging from $173.93 to $174.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $169.45 to $170.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $170.68 to $171.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $172.08 to $173.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $173.16 to $174.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $174.25 to $174.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F8This transaction was executed in multiple trades at prices ranging from $172.98 to $173.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $173.98 to $174.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.